The intravenous (iv) hydration therapy market has seen considerable growth due to a variety of factors.
•There has been substantial growth in the intravenous (IV) hydration therapy market in recent times. An upscale from $2.82 billion in 2024 to $3.05 billion in 2025 is projected, with a compound annual growth rate (CAGR) of 8.3%.
The increasing figures in the historic duration can be credited to elements such as medical treatments and procedures, athletic and sports performance, handling of dehydration in a clinical setting, recovery from illnesses, and the convenience of mobile and concierge services.
The intravenous (iv) hydration therapy market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of intravenous (IV) hydration therapy is anticipated to significantly increase in the forthcoming years, with an estimated value of $4.4 billion by 2029, and a compound annual growth rate (CAGR) of 9.6%.
The expected expansion during the forecast period is due to factors such as personalization focused on the consumer, inclusion in corporate health programs, preventative health strategies, the growth of fitness and wellness tourism, and the increased needs of an aging populace. The foreseeable trends during this period include sourcing in an ethical and sustainable manner, all-encompassing health retreats, hydration-focused bars and lounges, and an emphasis on mental wellness.
The escalating incidence of chronic illnesses is predicted to catalyze the growth of the intravenous (IV) hydration therapy market in the future. IV hydration therapy delivers vitamins and other vital nutrients, providing a significant energy surge for patients plagued by chronic diseases. For example, in September 2022, the World Health Organization, which is a specialised agency of the United Nations based in Switzerland, reported that there were 41 million deaths, a staggering 74% of which were due to non-communicable diseases (NCDs) or chronic diseases globally. Cardiovascular diseases accounted for 17.9 million deaths, cancer for 9.3 million deaths, chronic respiratory diseases for 4.1 million deaths, and diabetes for 2.0 million deaths. Therefore, the increasing incidence of chronic diseases is fueling the growth of the intravenous (IV) hydration therapy market.
The intravenous (IV) hydration therapy market covered in this report is segmented –
1) By Service: Immune Boosters, Energy Boosters, Skin Care, Migraine, Other Service
2) By Component: Medicated, Non-Medicated
3) By End-User: Hospitals And Clinics, Wellness Centers And Spas, Home Healthcare, Other End-Users
Subsegments:
1) By Immune Boosters: Vitamin C Infusion, Zinc Infusion, Glutathione Infusion
2) By Energy Boosters: B-Complex Vitamins Infusion, Amino Acids Infusion, Electrolyte Solutions
3) By Skin Care: Hydration Infusion, Anti-Aging Infusion, Detox Infusion
4) By Migraine: Pain Relief Infusion, Magnesium Infusion, Hydration Infusion
5) By Other Services: Hangover Relief Infusion, Weight Loss Infusion, Athletic Performance Infusion
Product innovation is emerging as a crucial trend within the intravenous (IV) hydration therapy market. The key corporations functioning within this market are embracing novel technologies to maintain their standing. For instance, Concierge Medical Consultants Inc., a Canadian group of board-certified doctors providing private, confidential, and tailored healthcare, expanded its services in Toronto and Vancouver in September 2022 with the introduction of Intravenous Vitamin Therapy (IV Therapy). This service addition comes with six different Vitamindrip product variations: hydration, recovery, energy, cosmetics, diet and detox, and immune boost. Vitamin drip, a scientifically developed intravenous solution, effectively deals with dehydration and related conditions including migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, and additional disorders.
Major companies operating in the intravenous (IV) hydration therapy market include:
• Revitalist
• JW Life Science Corporation
• NextGen Healthcare
• Pfizer Inc.
• Fresenius Kabi AG
• Liquid IV
• Medtronic Plc.
• Drip Hydration
• Amanta Healthcare Ltd.
• Becton Dickinson and Company
• Elixir
• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Sippex IV bag
• REVIV
• Braun Melsungen AG
• The IV Doc Inc.
• Terumo Medical Corporation
• Grifols S.A.
• Harpal Clinic Ltd.
• Fosmo Med
• Core IV Therapy LLC
• Cryojuvenate UK Ltd.
• Hospira
• Teleflex Incorporated
• Sichuan Kelun Pharmaceutical Co.Ltd.
• ICU Medical Inc.
• Vygon SAS
• Vifor Pharma Management AG
North America was the largest region in the intravenous (IV) hydration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (IV) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa